This topic covers the use of domain-specific large language models (e.g., GPT Rosalind), automated extraction agents, and production-grade data and analytics platforms to accelerate scientific research and support biodefense. By 2026 these technologies are being combined to index and synthesize literature, extract structured experimental facts, run reproducible analytic pipelines, and enable retrieval-augmented generation (RAG) for hypothesis generation and surveillance. Key trends include the maturation of specialized biomedical LLMs, the rise of agent frameworks to orchestrate multi-step workflows, and stronger emphasis on data governance, labeling quality, and safety controls. Practically, systems pair research search engines and RAG stacks (Researchspace-style search, Pinecone vector DBs for semantic retrieval) with agent frameworks (e.g., LangChain) that coordinate extraction agents to parse papers, protocols, and datasets. Data-centric platforms such as Scale AI provide labeling, model evaluation, and RLHF workflows to improve domain model accuracy and alignment. Analytics and operational tooling (Alteryx for governed analytics, Asana for project/workflow management, developer tools like Amazon CodeWhisperer) help teams move from prototyping to reproducible pipelines and production deployments. Lightweight browser tools (e.g., Xinsight) illustrate how contextual assistants can accelerate curation and outreach. Relevance and risks: the convergence of domain LLMs and agents makes faster discovery and operational surveillance possible, but also raises safety, provenance, and misuse concerns that must be managed via robust data governance, audit trails, and human-in-the-loop review. For practitioners in AI Research Tools, AI Data Platforms, and Data Analytics Tools, this landscape emphasizes integrated stacks—specialized models, vector search, agent orchestration, and label/safety platforms—to deliver reproducible, auditable, and safer biodefense and research workflows.